Cardiovascular Systems Analysis
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Cardiovascular Systems is overvalued with Real Value of 15.58 and Hype Value of 20.0. The main objective of Cardiovascular Systems delisted stock analysis is to determine its intrinsic value, which is an estimate of what Cardiovascular Systems is worth, separate from its market price. There are two main types of Cardiovascular Systems' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Cardiovascular Systems' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Cardiovascular Systems' stock to identify patterns and trends that may indicate its future price movements.
The Cardiovascular Systems stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Cardiovascular Systems is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Cardiovascular Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Cardiovascular Systems' ongoing operational relationships across important fundamental and technical indicators.
Cardiovascular |
Cardiovascular Stock Analysis Notes
About 90.0% of the company shares are held by institutions such as insurance companies. The book value of Cardiovascular Systems was currently reported as 5.7. The company has Price/Earnings (P/E) ratio of 724.24. Cardiovascular Systems recorded a loss per share of 0.96. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 26th of February 2009. Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people. For more info on Cardiovascular Systems please contact Scott Ward at 651 259 1600 or go to https://www.csi360.com.Cardiovascular Systems Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cardiovascular Systems' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cardiovascular Systems or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Cardiovascular Systems is not yet fully synchronised with the market data | |
| Cardiovascular Systems has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 236.22 M. Net Loss for the year was (36.93 M) with profit before overhead, payroll, taxes, and interest of 172.78 M. | |
| Cardiovascular Systems currently holds about 159.83 M in cash with (24.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.9. | |
| Over 90.0% of the company shares are held by institutions such as insurance companies |
Cardiovascular Systems Upcoming and Recent Events
Earnings reports are used by Cardiovascular Systems to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cardiovascular Systems previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 3rd of May 2023 Upcoming Quarterly Report | View | |
| 1st of August 2023 Next Financial Report | View | |
| 31st of March 2023 Next Fiscal Quarter End | View | |
| 1st of August 2023 Next Fiscal Year End | View | |
| 31st of December 2022 Last Quarter Report | View | |
| 30th of June 2022 Last Financial Announcement | View |
Cardiovascular Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 843.96 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cardiovascular Systems's market, we take the total number of its shares issued and multiply it by Cardiovascular Systems's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Cardiovascular Profitablity
Cardiovascular Systems' profitability indicators refer to fundamental financial ratios that showcase Cardiovascular Systems' ability to generate income relative to its revenue or operating costs. If, let's say, Cardiovascular Systems is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cardiovascular Systems' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cardiovascular Systems' profitability requires more research than a typical breakdown of Cardiovascular Systems' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.16) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.16) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.16. Cardiovascular Systems Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cardiovascular Systems insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cardiovascular Systems' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cardiovascular Systems insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Scott Ward over six months ago Disposition of 578310 shares by Scott Ward of Cardiovascular Systems subject to Rule 16b-3 |
Cardiovascular Systems Predictive Daily Indicators
Cardiovascular Systems intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Cardiovascular Systems stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About Cardiovascular Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Cardiovascular Systems prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cardiovascular shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Cardiovascular Systems. By using and applying Cardiovascular Stock analysis, traders can create a robust methodology for identifying Cardiovascular entry and exit points for their positions.
Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in Saint Paul, Minnesota. Cardiovascular Syst operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 725 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Cardiovascular Systems to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |